A Study Comparing the Effects and Safety of Dulaglutide With Insulin Glargine in Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine if once-weekly dulaglutide is efficient and safe
compared to once-daily insulin glargine in participants with type 2 diabetes mellitus who
have inadequate glycemic control with 1 or 2 oral antihyperglycemic medications (OAM)
(metformin and/or a sulfonylurea), in addition to any healthy lifestyle changes recommended
by their healthcare providers.